Cytokinetics Announces Primary Results from MAPLE-HCM Presented at the European Society of Cardiology Congress 2025 and Published in The New England Journal Of Medicine
Positive Trial Demonstrates Superiority of Aficamten to Standard-of-Care Beta-Blocker Metoprolol Primary Endpoint…
SAP Executives to Participate in Upcoming Investor Events in Q3 2025
WALLDORF, Germany, Aug. 26, 2025 /PRNewswire/ -- SAP SE (NYSE: SAP) today…
Zelluna ASA Reports Second Quarter 2025 Financial Results and Provides General Business Update
Oslo, Norway, 20 August 2025 – Zelluna (OSE: ZLNA), a company pioneering…
Milestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call
August 13, 2025 11:45 ET | Source: Milestone Scientific, Inc. ROSELAND, N.J.,…
BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update
Continued execution of BioNTech’s oncology strategy with focus on two pan-tumor programs…
DXP Enterprises, Inc. Announces Second Quarter 2025 Earnings Release and Conference Call
HOUSTON--(BUSINESS WIRE)--#dxpe--DXP Enterprises, Inc. (the “Company”) (NASDAQ: DXPE), a leading business to…
Apogee Therapeutics to Host Conference Call to Report Part A 16-Week Data from the Phase 2 APEX Trial of APG777 in Patients with Moderate-to-Severe Atopic Dermatitis on July 7, 2025
SAN FRANCISCO and BOSTON, July 06, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics,…
HUTCHMED to Announce 2025 Half-Year Financial Results
July 03, 2025 04:30 ET | Source: HUTCHMED (China) Limited HONG KONG…
Sandisk Announces Participation in Investor Conference
MILPITAS, Calif.--(BUSINESS WIRE)--Sandisk Corporation (NASDAQ: SNDK) announced today that management will participate…
PolyPid to Host Conference Call and Webcast to Discuss D-PLEX SHIELD II Phase 3 Trial Topline Results on Monday, June 9, 2025
June 06, 2025 16:05 ET | Source: PolyPid Ltd. PETACH TIKVA, Israel, June…